Coverage of the 2014 Conference on Retroviruses and Opportunistic Infections
- Details
- Category: HIV Treatment
- Published on Sunday, 09 March 2014 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 21st Conference on Retroviruses and Opportunistic infections (CROI 2014), March 3-6, 2014, in Boston.
Conference highlights include new treatments for hepatitis C, HIV experimental therapies and treatment strategies, HIV cure research, HIV-related conditions, treatment as prevention and PrEP, and HIV/HCV coinfection.
Full HIVandHepatitis.com coverage by topic
Selected presentations and slide webcasts
3/9/14
CROI 2014: Retrovirus Conference Now Underway in Boston
- Details
- Category: HIV Treatment
- Published on Monday, 03 March 2014 00:00
- Written by Liz Highleyman
The 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) kicked off in Boston this week with a program for young investigators, a press conference on new hepatitis C treatments, and opening lectures on HIV immune response and cross-species transmission and an update on the epidemic in West Africa.
HIVandHepatitis.com will be on site all week bringing you the latest news.
CROI 2014: Retrovirus Conference Starts Monday in Boston
- Details
- Category: HIV Treatment
- Published on Friday, 28 February 2014 00:00
- Written by HIVandHepatitis.com
The 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) will take place next week, March 3-6, at the Hynes Convention Center in Boston. HIVandHepatitis.com will be on site all week to bring you the latest news coverage about HIV, hepatitis C, and related topics.
CROI 2014: The Role of Interferon in HIV Response [VIDEO]
- Details
- Category: HIV Treatment
- Published on Monday, 03 March 2014 00:00
- Written by Gregory Fowler
Although interferon is on its way out as a standard of care for hepatitis C, researchers are learning more about its role in HIV, conference vice chair Julie Overbaugh said at a media briefing on the opening day of the 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) this week in Boston.
CROI 2013: Random Anal Biopsies Improve Detection of Pre-cancerous Lesions
- Details
- Category: HIV-Related Conditions
- Published on Wednesday, 10 April 2013 00:00
- Written by Matt Sharp
Performing random anal biopsies increases the rate of diagnosis of high-grade squamous intraepithelial lesions (HSIL) during high-resolution anoscopy, researchers from Mt. Sinai School of Medicine in New York City reported at the recent 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013).
More Articles...
- CROI 2013: Gene Therapy Studies Show Potential for HIV Control without Drugs
- CROI 2013: Growing Number of HIV+ New Yorkers Achieve Viral Load Suppression [VIDEO]
- CROI 2013: Antiretroviral Therapy Intensification plus IL-7 Does Not Reduce HIV Reservoir
- CROI 2013: Telaprevir Triple Therapy Improves HCV Response for Black Null Responders
Web Design and Development by